文献速递临床试验与 GCP

手术治疗与观察治疗中度间歇性外斜视(SOMIX):随机对照试验研究方案

Surgical treatment versus observation in moderate intermittent exotropia (SOMIX): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2023-03-01

SOMIX 研究为随机对照试验,计划在中国中山大学中山眼科中心纳入280例5至18岁中度间歇性外斜视患者,随机分为手术组与观察组,随访5年,主要比较两组治愈率,并分析影响长期结局的预测因素及自然病程。

要点

  • SOMIX 研究拟纳入280例5至18岁中度间歇性外斜视患者,随机分为手术组与观察组。
  • 主要目标为比较手术组与观察组的治愈率,随访期5年。
  • 次要目标包括识别各组影响长期结局的预测因素及观察间歇性外斜视的自然病程。

核心结论

  • SOMIX 试验将为中度间歇性外斜视及其管理提供重要指导,并改进间歇性外斜视的治疗策略。

研究设计与样本

  • SOMIX 为随机对照试验,计划在中山大学中山眼科中心纳入280例5至18岁中度间歇性外斜视患者,随机分为手术治疗组或观察组,随访5年。

主要发现

  • 主要目标为比较手术治疗组与观察组的治愈率。
  • 次要目标为识别各组影响长期结局的预测因素,并观察间歇性外斜视的自然病程。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intermittent exotropia (IXT) is the most common type of strabismus in China, but the best treatment and optimal timing of intervention for IXT remain controversial, particularly for children with moderate IXT who manifest obvious exodeviation frequently but with only partial impairment of binocular single vision. The lack of randomized controlled trial (RCT) evidence means that the true effectiveness of the surgical treatment in curing moderate IXT is still unknown. The SOMIX (surgical treatment versus observation in moderate intermittent exotropia) study has been designed to determine the long-term effectiveness of surgery for the treatment and the natural history of IXT among patients aged 5 to 18 years old. METHODS/DESIGN: A total of 280 patients between 5 and 18 years of age with moderate IXT will be enrolled at Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. After initial clinical assessment, all participants will be randomized to receive surgical treatment or observation, and then be followed up for 5 years. The primary objective is to compare the cure rate of IXT between the surgical treatment and observation group. The secondary objectives are to identify the predictive factors affecting long-term outcomes in each group and to observe the natural course of IXT. DISCUSSION: The SOMIX trial will provide important guidance regarding the moderate IXT and its managements and modify the treatment strategies of IXT. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02736526 . Registered April 13, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Shen T, Chen J, Kang Y, et al. Surgical treatment versus observation in moderate intermittent exotropia (SOMIX): study protocol for a randomized controlled trial. Trials. 2023. PMID: 36855155. doi:10.1186/s13063-023-07189-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。